Condition: Liver Cirrhosis · Portal Hypertension · Non-Cirrhotic Portal Hypertension · Sponsor: University Hospital Freiburg
Patients with clinically significant portal hypertension allocated to implantation of a transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Medicine II of the University Medical Center Freiburg, Germany will be offered to participate in this prospective observational trial. Clinical and laboratory as well as outcome parameters will be assessed before and within the first 12 months after TIPS implantation following a regular follow-up schedule with clinical visits at the University Medical Center Freiburg. During follow-up visits, serum/plasma samples and peripheral blood mononuclear cells (PBMC) are collected and stored in a associated biobank.
This description comes directly from the study's public registry record.
Dominik Bettinger, MD · 49761270-36870 · dominik.bettinger@uniklinik-freiburg.de
Always discuss trial participation with your own doctor first.
| University Medical Center Freiburg, Department of Medicine II | Freiburg im Breisgau, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05782556